Disclosed are novel substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing the compounds, methods of making the compounds, and methods of using the compounds to destroy a target cell, such as a cancer cell, and to treat or prevent a cancerous condition.
本发明涉及新的取代
四氢异喹啉化合物、含有该化合物的制药组合物、制备该化合物的方法,以及使用该化合物破坏目标细胞,如癌细胞,并治疗或预防癌症状况的方法。